IJCRR - 6(9), May, 2014
Pages: 80-88
ROLE OF ANTIOXIDANTS IN PREVENTION OF CANCER : A REVIEW
Author: Mobeen Khan, Asad Iqubal, Anuja Joshi, Kratika Ajai
Category: Healthcare
[Download PDF]
Abstract:
The realization that reactive oxygen species and oxidative stress play an important role in the etiology and progression of major human degenerative diseases has triggered enormous and worldwide interest in endogenous and exogenous antioxidants. Antioxidants are capable of stabilizing, or deactivating, free radicals before they attack cells. Antioxidants are absolutely critical for maintaining optimal cellular and systemic health and well-being. A biological antioxidant may be defined as “a substance present in low concentrations compared to an oxidizable substrate (eg., proteins, lipids, carbohydrates and nucleic acids) that significantly delays or inhibits oxidation of a substrate. Antioxidants may be considered as the scavengers of free radicals”. To protect the cells and organ systems of the body against reactive oxygen species, humans have evolved a highly sophisticated and complex antioxidant protection system.It involves a variety of components, both endogenous and exogenous in origin, that function interactively and synergistically to neutralize free radicals.
Keywords: Antioxidants, Free Radicals, Oxidizable Substrate
Citation:
Mobeen Khan, Asad Iqubal, Anuja Joshi, Kratika Ajai. ROLE OF ANTIOXIDANTS IN PREVENTION OF CANCER : A REVIEW International Journal of Current Research and Review. 6(9), May, 80-88
References:
REFERENCES
1. Rangan U, Bulkley GB. Prospects for treatment of free radical mediated tissue injury. Br med Bulletin, 1993; 49: 700-18.
2. Nicholas P. Antioxidants and stabilizers, Handbook of Polymer Science and Technology: Performance Properties.1997; 261-262.
3. Cheeseman KH, Slater TF. An introduction to free radial biochemistry. Br Med bulletin, 1993; 49:481-93.
4. Percival M. Antioxidants .Clinical Nutrition Insights, 1996; 1-4.
5. Abheri Das Sarma, AnisurRahamanMallick and A. K. Ghosh.Free Radicals and Their Role in Different Clinical Conditions: An Overview. International Journal of Pharma Sciences and Research, Vol. 1(3), 2010, 185- 192.
6. Kritchevsky D, Kritchevsky SB. Antioxidants and their role in coronary heart diseaseprevention. In: Basu TK, Temple NJ, Garg ML, eds. Antioxidants in Human Health andDisease. Wallingford, Oxon, UK: CAB International, 1999: 15 1-64.
7. Bendich A. Immunological role of antioxidant vitamins. In: Basu TK, Temple NJ, Garg ML,eds. Antioxidants in Human Health and Disease. Wallingford, Oxon, UK CAB International,1999: 27-41.
8. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases ofaging.Proc Nat1 AcadSci, USA 1993; 90:7915-22.
9. Dusinska M, Lietava J, Olmedilla B, Raslova K, Southon S, Collins AR. Indicators of oxidativestress, antioxidants and human health. In: Basu TK, Temple NJ, Garg ML, eds. Antioxidants inHuman Health and Disease. Wallingford, Oxon, UK: CAB International, 1999: 4 I I-22.
10. Hannon-Fletcher M, Hughes C, O’Kane MJ, Moles KW, Barnett CR, Barnett YA. Aninvestigation of in vivo antioxidant status and DNA damage in patients with IDDM. In. BasuTK, Temple NJ, Garg ML, eds. Antioxidants in Human Health and Disease. Wallingford,Oxon, UK: CAB International, 1999: 259-69.
11. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann RheumDis 1995; 54:505-10.
12. Young IS, Roxborough HE, Woodside JV. Antioxidants and respiratory disease. In: Basu TK,Temple NJ, Garg ML, eds. Antioxidants in Human Health and Disease. Wallingford. Oxon,UK: CAB International, 1999: 293-3 11.
13. Taylor A, Jacques P, Epstein E. Nutrition and the risk for cataract. In: Basu TK, Temple NJ,Garg ML, eds. Antioxidants in Human Health and Disease. Wallingford, Oxon, UK. CABInternational, 1999: 27 l-84.
14. Nath R, Gupta A, Prasad R, Pandav SS, Thakur R. Reactive oxygen species and agerelatedmacular degeneration. In: Basu TK, Temple NJ, Garg ML, eds. Antioxidants in Human Healthand Disease. Wallingford, Oxon, UK: CAB International, 1999: 285-92.
15. Martins RN, Chan CW, Waddington E, Veurink G, Laws S, Croft K, Dharmarajan AM. Betaamyloidand oxidative stress in the pathogenesis of Alzheimer’s disease. In: Basu TK, TempleNJ, Garg ML, eds. Antioxidants in Human Health and Disease. Wallingford, Oxon, UK: CABInternational, 1999: 367-91,
16. Reddy R, Yao JK. Schizophrenia: role of oxidative stress and essential fatty acids. In. Basu TK,Temple NJ, Garg ML, eds. Antioxidants in Human Health and Disease. Wallingford, Oxon,UK: CAB International, 1999: 35 l-66
17. Hu G, Zhang X, Chen J, Peto R, Campbell TC, Cassano PA. Dietary vitamin C intake and lungfunction in rural China.Am J Epidemiol 1998; 148:594-9.
18. Panayiotidis M, Collins AR. Ex vivo assessment of lymphocyte antioxidant status using the comet assay. Free Radic Res 1997; 27:533-7.
19. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes.Cancer Res 1996; 56:1291-5.
20. Santos MS, Meydani SN, Leka L. Wu D, Fotouhi N, Meydani M, Hennekens CH, Gaziano JM.Natural killer cell activity in elderly men is enhanced by p-carotene supplementation. Am J ClinNutr 1997; 64:772-7
21. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119:598-620.
22. Halliwell B. Antioxidants in human health and disease. Ann Rev Nutr 1996; 16:33-50.
23. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenolsreduces the susceptibility of lowdensity lipoproteins to oxidation in vivo. Am J ClinNutr 1998;68:258-65.
24. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption andreduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ 1996;3 12:73 1-6.
25. T.N. Uma Maheswari. Treatment of oral leukoplakia with antioxidants – a systematic review.Int J Pharma Bio Sci 2013 Oct; 4(4): (p) 33- 41.
26. S. T. Mayne, Beta-carotene, carotenoids, and disease prevention in humans.The FASEB Journal, 10(7): 690–701, (1996).
27. Stephen Hsu, Baldev Singh, George Schuster. Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. OralOncology 2003; 0: 1-13.
28. Van Poppel G. van den Berg H. Vitamins and cancer. Cancer Lett. 1997; 114(1-2): 195-202.
29. SimmiKharb, Rajnish Jain, S. C. Anand. Salivary Vitamin E and C in Lichen Planus.Gomal J Med Sci 2008; 6(2): 91-2.
30. Beenadas. Antioxidants in the treatment and prevention of oral cancer. Kerala Dental Journal 2008; 31(4):24-33.
31. Rao AV, Agarwal S. Role of antioxidant lycopene in cancer and heart disease. Journal of the American College of Nutrition 2000; 19(5): 563-9.
32. Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 1998; 20: 528-34. 3
3. Hsu S, Singh B, Lewis JE, Borke JL, Dickinson DP, Drake L, et al. Chemoprevention of oral cancer by green tea. Gen Dentistry 2001; 50(2): 140-6.
34. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, et al. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)- epigallocatechingallate and green tea--a review. Cancer Detect Prev 2000; 24: 91-9.
35. Sankaranarayanan R, Mathew B, Varghese C, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncology1997; 33(4): 231-6.
36. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc1996; 96:1027-39.
37. Block G, Patterson BH, Subar AF. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: l-29.
38. Block G. Vitamin C and cancer prevention: the epidemiological evidence. Am J ClinNutr 53,270S-32S, 1991.
39. Byers T, Guerrero N. Epidemiologic evidence for vitamin C and vitamin E in cancerprevention. Am J ClinNutr 1995; 62:13858-928.
40. Van Poppel G, Goldbohm RA. Epidemiologic evidence for p-carotene and cancer prevention.Am J ClinNutr 1995; 62:1393S- 4028.
41. Greenwald P, McDonald SS. Antioxidants and the prevention of cancer. In: Basu TK, TempleNJ, Garg ML, eds. Antioxidants in Human Health and Disease. Wallingford, Oxon, UK: CABInternational, 1999: 217-34.
42. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: Review of theepidemiological literature. J Nat1 Cancer Inst 1999; 91:3 17-32.
43. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttenen JK, Hartman AM, Haapakoski J,Malila M, Rautalahti M, Ripatti S, Maenpaa H, Teerenhovi L, Koss L, Virolainen M, EdwardsBK. Prostate cancer and supplementation with u-tocopherol and pcarotene: incidence andmortality in acontrolled trial. J Natl Cancer Inst 1998; 90:440-6.
44. Alpha-Tocopherol Carotene Cancer Prevention Study Group. The effect of vitamin E andcarotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med1994; 330:1029-35.
45. Omenn GS, Goodman GE, Thomquist MD, Balmes J, Cullen MR, Glass A, Keogh JP,Meyskens FL, Valanis B, Williams JH, Barnhart S, Cherniack MG, Brodkin CA, Hammar S.Risk factors for lung cancer and for intervention effects in CARET, the p-carotene and RetinolEfficacy Trial. J Natl Cancer Inst 1996; 88: 1550-9.
46. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP,Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination ofcarotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334: 1150-5.
47. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C,LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of longtermsupplementation with carotene on the incidence of malignant neoplasms and cardiovasculardisease. N Engl J Med 1996; 334: 1145-9.
48. Garewal HS, Meyskens FL, Killen D, Reeves D, Kiersch TA, Elletson H, Strosberg A, King D,Steinbronn K. Response of oral leukoplakia to p-carotene. J ClinOncol 1990; 8: 1715-20.
49. Bukin YV, Draudin-Krylenko VA. The role of carotene and vitamin E in the treatment of early gastric premalignant lesions: biochemical and clinical aspects. In: Basu TK, Temple NJ, GargML, eds. Antioxidants in Human Health and Disease. Wallingford, Oxon, UK: CABInternational, 1999: 235-48.
50. Stitch HF, Stitch W, Rosin MP, Vallejera MO. Use of the micronucleus test to monitor theeffect of vitamin A, beta-carotene and canthaxanthin on the buccal mucosa of betel nut/tobaccochewers. Int J Cancer 1984; 34:745-50.
51. Track B, Lanza E, Greenwald P. Dietary fiber, vegetables, and colon cancer: critical reviewand meta-analysis of the epidemiological evidence. J Natl Cancer Inst 1990; 82:650-61.
52. Heaton KW. Dietary fiber. In: Temple NJ, Burkitt DP, eds. Western Diseases: their Dietary Prevention and Reversibility. Totowa, NJ: Humana Press, 1994: 187-208.
53. Nestle M. Broccoli sprouts in cancer prevention. Nutr Rev 1998; 56: 127-30.
54. Graham S, Mettlin C. Diet and colon cancer. Am J Epidemiol 1979; 109: l-2
|